|
1
|
Adamietz IA and Niederle N: Lung cancer.
Onkologe. 16:615–628. 2010.(In German). View Article : Google Scholar
|
|
2
|
Herman JG and Baylin SB: Gene silencing in
cancer in association with promoter hypermethylation. N Engl J Med.
349:2042–2054. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Licchesi JD, Westra WH, Hooker CM and
Herman JG: Promoter hypermethylation of hallmark cancer genes in
atypical adenomatous hyperplasia of the lung. Clin Cancer Res.
14:2570–2578. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yanagawa N, Tamura G, Oizumi H, Kanauchi
N, Endoh M, Sadahiro M and Motoyama T: Promoter hypermethylation of
RASSF1A and RUNX3 genes as an independent prognostic prediction
marker in surgically resected non-small cell lung cancers. Lung
Cancer. 58:131–138. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Feng Q, Hawes SE, Stern JE, Wiens L, Lu H,
Dong ZM, Jordan CD, Kiviat NB and Vesselle H: DNA methylation in
tumor and matched normal tissues from non-small cell lung cancer
patients. Cancer Epidemiol Biomarkers Prev. 17:645–654. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ali AH, Kondo K, Namura T, Senba Y,
Takizawa H, Nakagawa Y, Toba H, Kenzaki K, Sakiyama S and Tangoku
A: Aberrant DNA methylation of some tumor suppressor genes in lung
cancers from workers with chromate exposure. Mol Carcinog.
50:89–99. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kim H, Kwon YM, Kim JS, Lee H, Park JH,
Shim YM, Han J, Park J and Kim DH: Tumor-specific methylation in
bronchial lavage for the early detection of non-small-cell lung
cancer. J Clin Oncol. 22:2363–2370. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Begum S, Brait M, Dasgupta S, Ostrow KL,
Zahurak M, Carvalho AL, Califano JA, Goodman SN, Westra WH, Hoque
MO and Sidransky D: An epigenetic marker panel for detection of
lung cancer using cell-free serum DNA. Clin Cancer Res.
17:4494–4503. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Leng S, Do K, Yingling CM, Picchi MA, Wolf
HJ, Kennedy TC, Feser WJ, Baron AE, Franklin WA, Brock MV, et al:
Defining a gene promoter methylation signature in sputum for lung
cancer risk assessment. Clin Cancer Res. 18:3387–3395. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang J, Shen Y, Liu B and Tong Y: Promoter
methylation of BRMS1 correlates with smoking history and poor
survival in non-small cell lung cancer patients. Lung Cancer.
74:305–309. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu Y, Lan Q, Shen M, Jin J, Mumford J,
Ren D and Keohavong P: Aberrant gene promoter methylation in sputum
from individuals exposed to smoky coal emissions. Anticancer Res.
28:2061–2066. 2008.PubMed/NCBI
|
|
12
|
Brabender J, Usadel H, Metzger R,
Schneider PM, Park J, Salonga D, TsaoWei DD, Groshen S, Lord RV,
Takebe N, et al: Quantitative O(6)-methylguanine DNA
methyltransferase methylation analysis in curatively resected
non-small cell lung cancer: Associations with clinical outcome.
Clin Cancer Res. 9:223–227. 2003.PubMed/NCBI
|
|
13
|
DeJong WK, Verpooten GF, Kramer H,
Louwagie J and Groen HJ: Promoter methylation primarily occurs in
tumor cells of patients with non-small cell lung cancer. Anticancer
Res. 29:363–369. 2009.PubMed/NCBI
|
|
14
|
Lin Q, Geng J, Ma K, Yu J, Sun J, Shen Z,
Bao G, Chen Y, Zhang H, He Y, et al: RASSF1A, APC, ESR1, ABCB1 and
HOXC9, but not p16INK4A, DAPK1, PTEN and MT1G genes were frequently
methylated in the stage I non-small cell lung cancer in China. J
Cancer Res Clin Oncol. 135:1675–1684. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Maruyama R, Sugio K, Yoshino I, Maehara Y
and Gazdar AF: Hypermethylation of FHIT as a prognostic marker in
nonsmall cell lung carcinoma. Cancer. 100:1472–1477. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Safar AM, Spencer H III, Su X, Coffey M,
Cooney CA, Ratnasinghe LD, Hutchins LF and Fan CY: Methylation
profiling of archived non-small cell lung cancer: A promising
prognostic system. Clin Cancer Res. 11:4400–4405. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Toyooka S, Maruyama R, Toyooka KO,
McLerran D, Feng Z, Fukuyama Y, Virmani AK, ZochbauerMuller S,
Tsukuda K, Sugio K, et al: Smoke exposure, histologic type and
geography-related differences in the methylation profiles of
non-small cell lung cancer. Int J Cancer. 103:153–160. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jin H, Wang X, Ying J, Wong AH, Cui Y,
Srivastava G, Shen ZY, Li EM, Zhang Q, Jin J, et al: Epigenetic
silencing of a Ca(2+)-regulated Ras GTPase-activating protein RASAL
defines a new mechanism of Ras activation in human cancers. Proc
Natl Acad Sci USA. 104:12353–12358. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ohta M, Seto M, Ijichi H, Miyabayashi K,
Kudo Y, Mohri D, Asaoka Y, Tada M, Tanaka Y, Ikenoue T, et al:
Decreased expression of the RAS-GTPase activating protein RASAL1 is
associated with colorectal tumor progression. Gastroenterology.
136:206–216. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Calvisi DF, Ladu S, Conner EA, Seo D,
Hsieh JT, Factor VM and Thorgeirsson SS: Inactivation of Ras
GTPase-activating proteins promotes unrestrained activity of
wild-type Ras in human liver cancer. J Hepatol. 54:311–319. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Seto M, Ohta M, Ikenoue T, Sugimoto T,
Asaoka Y, Tada M, Mohri D, Kudo Y, Ijichi H, Tateishi K, et al:
Reduced expression of RAS protein activator like-1 in gastric
cancer. Int J Cancer. 128:1293–1302. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang H, Ozaki I, Mizuta T, Hamajima H,
Yasutake T, Eguchi Y, Ideguchi H, Yamamoto K and Matsuhashi S:
Involvement of programmed cell death 4 in transforming growth
factor-betal-induced apoptosis in human hepatocellular carcinoma.
Oncogene. 25:6101–6112. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen Y, Knösel T, Kristiansen G, Pietas A,
Garber ME, Matsuhashi S, Ozaki I and Petersen I: Loss of PDCD4
expression in human lung cancer correlates with tumour progression
and prognosis. J Pathol. 200:640–646. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Woenckhaus M, KleinHitpass L, Grepmeier U,
Merk J, Pfeifer M, Wild P, Bettstetter M, Wuensch P, Blaszyk H,
Hartmann A, et al: Smoking and cancer-related gene expression in
bronchial epithelium an non-small-cell lung cancers. J Pathol.
210:192–204. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Dawson JC, Timpson P, Kalna G and Machesky
LM: Mtss1 regulates epidermal growth factor signaling in head and
neck squamous carcinoma cells. Oncogene. 31:1781–1793. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu K, Wang G, Ding H, Chen Y, Yu G and
Wang J: Downregulation of metastasis suppressor 1 (MTSS1) is
associated with nodal metastasis and poor outcome in Chinese
patients with gastric cancer. BMC Cancer. 10:4282010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xie F, Ye L, Chen J, Wu N, Zhang Z, Yang
Y, Zhang L and Jiang WG: The impact of metastasis suppressor-1,
MTSS1, on oesophageal squamous cell carcinoma and its clinical
significance. J Transl Med. 9:952011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jahid S, Sun J, Edwards RA, Dizon D,
Panarelli NC, Milsom JW, Sikandar SS, Gümüs ZH and Lipkin SM:
miR-23a promotes the transition from indolent to invasive
colorectal cancer. Cancer Discov. 2:540–553. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lam DC, Girard L, Suen WS, Chung L, Tin
VP, Lam WK, Minna JD and Wong MP: Establishment and expression
profiling of new lung cancer cell lines from Chinese smokers and
lifetime never-smokers. J Thorac Oncol. 1:932–942. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bova GS, MacGrogan D, Levy A, Pin SS,
Bookstein R and Isaacs WB: Physical mapping of chromosome 8p22
markers and their homozygous deletion in a metastatic prostate
cancer. Genomics. 35:46–54. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pils D, Horak P, Vanhara P, Anees M, Petz
M, Alfanz A, Gugerell A, Wittinger M, Gleiss A, Auner V, et al:
Methylation status of TUSC3 is a prognostic factor in ovarian
cancer. Cancer. 119:946–954. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ahuja N, Li Q, Mohan AL, Baylin SB and
Issa JP: Aging and DNA methylation in colorectal mucosa and cancer.
Cancer Res. 58:5489–5494. 1998.PubMed/NCBI
|
|
33
|
Guervòs MA, Marcos CA, Hermsen M, Nuño AS,
Suárez C and Llorente JL: Deletions of N33, STK11 and TP53 are
involved in the development of lymph node metastasis in larynx and
pharynx carcinomas. Cell Oncol. 29:327–334. 2007.PubMed/NCBI
|
|
34
|
Scholz C, Nimmrich I, Burger M, Becker E,
Dörken B, Ludwig WD and Maier S: Distinction of acute lymphoblastic
leukemia from acute myeloid leukemia through microarray-based DNA
methylation analysis. Ann Hematol. 84:236–244. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zemlyakova VV, Zhevlova AI, Zborovskaya
IB, Strelnikov VV, Laktionov KK, Zaletaev DV and Nemtsova MV:
Methylation profile of several tumor suppressor genes in
non-small-cell lung cancer. Mol Biol. 37:836–840. 2003. View Article : Google Scholar
|
|
36
|
Bettstetter M, Dechant S, Ruemmele P,
Vogel C, Kurz K, Morak M, Keller G, HolinskiFeder E, Hofstaedter F
and Dietmaier W: MethyQESD, a robust and fast method for
quantitative methylation analyses in HNPCC diagnostics using
formalin-fixed and paraffin-embedded tissue samples. Lab Invest.
88:1367–1375. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kubo T, Yamamoto H, Ichimura K, Jida M,
Hayashi T, Otani H, Tsukuda K, Sano Y, Kiura K and Toyooka S: DNA
methylation in small lung adenocarcinoma with bronchioloalveolar
carcinoma components. Lung Cancer. 65:328–332. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lee SM, Lee WK, Kim DS and Park JY:
Quantitative promoter hypermethylation analysis of RASSF1A in lung
cancer: Comparison with methylation-specific PCR technique and
clinical significance. Mol Med Rep. 5:239–244. 2012.PubMed/NCBI
|
|
39
|
Kristensen LS, Mikeska T, Krypuy M and
Dobrovic A: Sensitive melting analysis after real time-methylation
specific PCR (SMART-MSP): High-throughput and probe-free
quantitative DNA methylation detection. Nucleic Acids Res.
36:e422008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Grote HJ, Schmiemann V, Kazimirek M and
Böcking A: Quantitative methylation-specific PCR for the diagnosis
of lung cancer. Pathologe. 28:377–383. 2007.(In German). View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Cao Z, Yoon JH, Nam SW, Lee JY and Park
WS: PDCD4 expression inversely correlated with miR-21 levels in
gastric cancers. J Cancer Res Clin Oncol. 138:611–619. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Utikal J, Gratchev A, MullerMolinet I,
Oerther S, Kzhyshkowska J, Arens N, Grobholz R, Kannookadan S and
Goerdt S: The expression of metastasis suppressor MIM/MTSS1 is
regulated by DNA methylation. Int J Cancer. 119:2287–2293. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Fan H, Chen L, Zhang F, Quan Y, Su X, Qiu
X, Zhao Z, Kong KL, Dong S, Song Y, et al: MTSS1, a novel target of
DNA methyltransferase 3B, functions as a tumor suppressor in
hepatocellular carcinoma. Oncogene. 31:2298–2308. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Leupold JH, Asangani IA, Mudduluru G and
Allgayer H: Promoter cloning and characterization of the human
programmed cell death protein 4 (pdcd4) gene: Evidence for ZBP-89
and Sp-binding motifs as essential Pdcd4 regulators. Biosci Rep.
32:281–297. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Garshasbi M, Hadavi V, Habibi H, Kahrizi
K, Kariminejad R, Behjati F, Tzschach A, Najmabadi H, Ropers HH and
Kuss AW: A defekt in the TUSC3 gene is associated with autosomal
recessive mental retardation. Am J Hum Genet. 82:1158–1164. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Levy A, Dang UC and Bookstein R:
High-density screen of human tumor cell lines for homozygous
deletions of loci on chromosome arm 8p. Genes Chromosomes Cancer.
24:42–47. 1999. View Article : Google Scholar : PubMed/NCBI
|
